A

Acusphere Inc
OTC:ACUS

Watchlist Manager
Acusphere Inc
OTC:ACUS
Watchlist
Price: 0.001 USD 900% Market Closed
Market Cap: 5 USD

Operating Margin
Acusphere Inc

-1 582.4%
Current
-2 232%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 582.4%
=
Operating Profit
-42.5m
/
Revenue
2.7m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Acusphere Inc
OTC:ACUS
5 USD
-1 582%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
491.8B USD
27%
CH
Roche Holding AG
SIX:ROG
271.4B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP
24%
US
Merck & Co Inc
NYSE:MRK
274.9B USD
38%
CH
Novartis AG
SIX:NOVN
218.8B CHF
33%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
144.9B USD
29%
No Stocks Found

Acusphere Inc
Glance View

Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).

ACUS Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 582.4%
=
Operating Profit
-42.5m
/
Revenue
2.7m
What is the Operating Margin of Acusphere Inc?

Based on Acusphere Inc's most recent financial statements, the company has Operating Margin of -1 582.4%.

Back to Top